Verition Fund Management
VRCA icon

Verition Fund Management’s Verrica Pharmaceuticals VRCA Stock Holding History

Verition Fund Management’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6,164
Closed -$89.4K – 3545
2024
Q3 		$89.4K Buy
+6,164
New +$278K ﹤0.01% 3010
2023
Q3 		– Sell
-1,493
Closed -$86.1K – 2708
2023
Q2 		$86.1K Buy
1,493
+367
+33% +$22.3K ﹤0.01% 1995
2023
Q1 		$73.2K Buy
+1,126
New +$68.1K ﹤0.01% 1935

Other funds holding VRCA

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SA
Sovran Advisors San Diego, California $1.34B AUM 21.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Verition Fund Management's VRCA Position: Q4 2024 in Review

Verition Fund Management sold out of Verrica Pharmaceuticals (VRCA) in Q4 2024, closing a stake of 6,164 shares — an estimated $89.4K sold.

Verition Fund Management first reported a position in VRCA in Q1 2023 and held it in 3 quarters. The position peaked at $89.4K in Q3 2024. 81 funds tracked by Wall St. Rank hold VRCA as of Q4 2024.

  • Verition Fund Management reported no remaining Verrica Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Verition Fund Management sold 6,164 Verrica Pharmaceuticals shares in Q4 2024, an estimated $89.4K.
  • Verition Fund Management first reported a position in Verrica Pharmaceuticals in Q1 2023 and held it in 3 quarters.
  • Verition Fund Management's Verrica Pharmaceuticals position peaked at $89.4K in Q3 2024.
  • 81 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q4 2024.

Based on Verition Fund Management's 13F filing for Q4 2024, filed 14 Feb 2025.